- Home
- LTRY vs MYNZ Comparison
LTRY vs MYNZ Comparison
Compare LTRY & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- MYNZ
- Stock Information
- Founded
- LTRY 2015
- MYNZ 2021
- Country
- LTRY United States
- MYNZ Germany
- Employees
- LTRY N/A
- MYNZ N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- LTRY Technology
- MYNZ Health Care
- Exchange
- LTRY Nasdaq
- MYNZ Nasdaq
- Market Cap
- LTRY N/A
- MYNZ 5.5M
- IPO Year
- LTRY N/A
- MYNZ 2021
- Fundamental
- Price
- LTRY $1.19
- MYNZ $1.92
- Analyst Decision
- LTRY
- MYNZ Buy
- Analyst Count
- LTRY 0
- MYNZ 2
- Target Price
- LTRY N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- LTRY 1.1M
- MYNZ 154.3K
- Earning Date
- LTRY 08-18-2025
- MYNZ 07-22-2025
- Dividend Yield
- LTRY N/A
- MYNZ N/A
- EPS Growth
- LTRY N/A
- MYNZ N/A
- EPS
- LTRY N/A
- MYNZ N/A
- Revenue
- LTRY $1,030,318.00
- MYNZ $893,991.00
- Revenue This Year
- LTRY N/A
- MYNZ $26.06
- Revenue Next Year
- LTRY N/A
- MYNZ $4.97
- P/E Ratio
- LTRY N/A
- MYNZ N/A
- Revenue Growth
- LTRY N/A
- MYNZ N/A
- 52 Week Low
- LTRY $0.22
- MYNZ $1.34
- 52 Week High
- LTRY $2.65
- MYNZ $20.08
- Technical
- Relative Strength Index (RSI)
- LTRY 46.73
- MYNZ 57.87
- Support Level
- LTRY $1.27
- MYNZ $1.35
- Resistance Level
- LTRY $1.37
- MYNZ $2.15
- Average True Range (ATR)
- LTRY 0.10
- MYNZ 0.13
- MACD
- LTRY -0.00
- MYNZ 0.10
- Stochastic Oscillator
- LTRY 33.33
- MYNZ 71.67
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.